Lumos Pharma
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Lumos Pharma generated cash of -$31,095,000, which is less than the previous year. Cash used in financing activities reached the amount of -$576,000 last year. Net change in cash is therefore -$20,929,000.
Cash Flow
| 2014 | 109.06M | -13.84M | 33.88M |
|---|---|---|---|
| 2015 | -24.08M | 6.21M | 23.08M |
| 2016 | -65.94M | -66K | 1.88M |
| 2017 | -48.28M | 211K | 75.28M |
| 2018 | -37.93M | 117K | -148K |
| 2019 | -30.20M | 77K | -59K |
| 2020 | -22.99M | 116.64M | 75K |
| 2021 | -29.64M | 25.97M | -192K |
| 2022 | -26.62M | -11.35M | -821K |
| 2023 | -31.09M | 10.74M | -576K |
LUMO Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 56.00M | 94.80M | 98.67M | 4.95M | 120.73M | 158.70M | 131.49M | 195.62M | 190.40M | 61.29M |
Operating activities | ||||||||||
Net income | -34.03M | -31.06M | -30.43M | -5.66M | -42.98M | -53.59M | -71.95M | -85.15M | -40.38M | 102.85M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 44K | 49K | 203K | 584K | 1.09M | 1.14M | 1.40M | 2.08M | 1.59M | 1.09M |
Stock-based compensation expense | 2.32M | 2.32M | 2.87M | 1.07M | 6.72M | 0 | 18.50M | 16.70M | 15.94M | 8.61M |
| Deferred income tax benefit | 2.32M | 2.32M | 2.87M | 1.07M | 6.72M | 0 | 18.50M | 16.70M | 15.94M | 8.61M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 13K | -92K | 136K | 309K | 0 | 10.22M | 14.35M | -19.13M | -1.65M | 0 |
Inventories | 0 | 92K | -136K | -309K | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 273K | 1.69M | -1.36M | -3.19M | 1.97M | -13.02M | -15.46M | 24.77M | 245K | 7.89M |
Cash generated by operating activities | -31.09M | -26.62M | -29.64M | -22.99M | -30.20M | -37.93M | -48.28M | -65.94M | -24.08M | 109.06M |
Investing activities | ||||||||||
Purchases Of Investments | -7.37M | -11.33M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -17.37M |
Investments In Property Plant And Equipment | 0 | -21K | -30K | -30K | -2K | -7K | -43K | -2.24M | -3.99M | -1.7M |
Acquisitions Net | 0 | 0 | 0 | 84.17M | 0 | 124K | 254K | 0 | 0 | 12.14M |
Cash generated by investing activities | 10.74M | -11.35M | 25.97M | 116.64M | 77K | 117K | 211K | -66K | 6.21M | -13.84M |
Financing activities | ||||||||||
Common Stock Issued | 725K | 0 | -78K | 116.94M | 0 | 294K | 74.41M | 2.22M | 13.53M | 27.57M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -1.31M | -675K | -114K | 0 | -36K | -275K | -289K | -82K | -561K | -222K |
Repayments of term debt | 0 | 0 | 0 | -27K | 0 | -167K | -246K | -257K | -194K | -187K |
Cash used in financing activities | -576K | -821K | -192K | 75K | -59K | -148K | 75.28M | 1.88M | 23.08M | 33.88M |
Net Change In Cash | -20.92M | -38.80M | -3.87M | 93.72M | -30.18M | -37.97M | 27.21M | -64.13M | 5.21M | 129.11M |
Cash at end of period | 35.07M | 56.00M | 94.80M | 98.67M | 90.54M | 120.73M | 158.70M | 131.49M | 195.62M | 190.40M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |